Grifols (GRFS) has established a partnership with the Biomedical Advanced Research and Development Authority to test investigational ocular ...

Given the company’s ceo transition coupled with the current state of the business, guidance will be suspended for the full fiscal year 2025. This will allow ample opportunity to complete an assessment ...

Pfizer (PFE) announced that the U.S. FDA has approved Abrysvo, the company’s bivalent RSV prefusion F vaccine, for the prevention of ...

Martin Midstream Partners (MMLP), or MMLP, shareholders Nut Tree Capital and Caspian Capital intend to oppose the proposed sale of Martin ...

Disney (DIS) has pulled the Marvel film “Blade” from its 2025 release schedule and says it will release “Predator: ...

Piper Sandler analyst Matthew Clark maintained a Hold rating on Zions Bancorporation National Association (ZION – Research Report) today ...

Stocks wavered on Tuesday, with investors assessing this week's bond market sell-off that pushed the 10-year to its highest ...

Our non-GAAP operating expenses were $81.6 million in the third quarter of 2024, compared to $81.7 million in the second quarter of 2024. Our non-GAAP operating income was $101.4 million in the third ...

HeartCore Enterprises (HTCR) announced a strategic shift from annual contracts to multi-year agreements around its core software business ...

In a report released today, Anita Soni from CIBC maintained a Hold rating on IAMGOLD (IAG – Research Report), with a price target of ...

Cigna (CI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Adam Ron from Bank of ...

Four decades of pioneering medical achievement have positioned the Stem Cell Centre as one of the largest globally for bone marrow transplants, according to the Center for International Blood & Marrow ...